Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters

Novavax stock crumbled Monday after the Food and Drug Administration signed off on updated Covid boosters from rivals Pfizer and Moderna.

Investors Business Daily

FDA approves updated Moderna and Pfizer Covid boosters set to arrive soon as cases rise – latest

An updated Coronavirus booster that targets a new variant is expected to be made available in September

The Independent UK

New Covid boosters approved as CDC set to decide who should receive them amid rising cases

Health officials say that the Pfizer and Moderna shots likely to be available later this week

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

US approves updated COVID vaccines to rev up protection this fall

U.S. regulators have approved updated COVID-19 vaccines from Pfizer and Moderna, shots aimed at revving up protection this fall and winter

The Independent UK

New COVID vaccines get FDA approval

Vaccines for a fall immunization drive against COVID-19 just got the green light from the Food and Drug Administration. The agency says the vaccines can protect people, as hospitalizations tick up.

WEKU

FDA greenlights new COVID-19 shots for this fall - Roll Call

The FDA approved reformulated COVID-19 vaccines from Pfizer and Moderna, but deferred an expected authorization for Novavax’s vaccine.

Roll Call

Poor countries face vaccine inequity

Vaccination is a global strategy, yet many low-income countries can't access then, perpetuating the pandemic

Salon

Read news from The Economist, FT, and more,
with one subscription

This Biotech Stock Offers Innovative Growth at a Massive Discount

Moderna stock continues to sag, even as new COVID variants emerge. However, investors may be underestimating the potential of the mRNA pipeline.

Barchart

FDA approves updated Moderna and Pfizer Covid boosters set to arrive soon as cases rise: Latest

An updated Coronavirus booster that targets a new variant is expected to be made available in September

The Independent UK

Jets' Aaron Rodgers shows support for unvaccinated tennis star Novak Djokovic

Aaron Rodgers crossed an item off his sports bucket list and then made a statement with a more visible crossout

The Independent UK

New Covid variant ‘Pirola’ sparks case rise across US and Canada as Moderna shares vaccine update – latest

An updated Coronavirus booster that targets a new variant is expected to be made available in September

The Independent UK

Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant

Moderna stock slipped Wednesday after the company said its updated Covid vaccine can take on a highly mutated strain nicknamed "pirola."

Investors Business Daily

Market Rally Attempt Suffers Big Reversal Amid Nvidia Earnings, Powell Speech: Weekly Review

A market rally attempt gained momentum, until Thursday's ugly reversal despite blowout Nvidia earnings. Fed chief Jerome Powell was hawkish Friday.

Investors Business Daily

S&P 500: Cybersecurity Giant Soars On Earnings; Tesla, Nvidia Are Big Winners

Palo Alto surged Monday after earnings, leading the S&P 500. Megacaps Tesla and NVDA were big winners too, with Nvidia earnings looming.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Moderna Surges On A Second, Unexpected Shot At The Cancer Vaccine Market

Moderna stock surged Monday after the biotech company inked a deal with China's Carsgen to study a new cancer vaccine regimen.

Investors Business Daily

Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance

Pfizer stock and Moderna stock dipped Friday — giving back some of their late Thursday gains on an upswing related to their updated Covid shots.

The Guardian - UK

Former Covid medical officer Van-Tam takes role at vaccine maker Moderna

One of UK’s public faces of pandemic, ‘JVT’ was known for football-related metaphors in No 10 briefings

The Guardian - UK

Covid booster jabs could go on sale privately in UK in 2024

Health officials reiterate support for private provision as lower age limit for NHS booster vaccines raised to 65

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Ex-medical chief Jonathan Van-Tam takes job with Covid vaccine giant Moderna

Move may spark fresh questions over ‘revolving door’ between government and business

Inverse

When Should You Get Your Next Covid-19 Booster? There’s One Easy Answer To This Question

Vaccine manufacturers like Pfizer/BioNTech, Moderna, and Novavax are switching up their shots in preparation for the new season.

The Guardian - UK

Covid vaccines should be available to buy privately in UK, scientists say

People not eligible for autumn booster programme should have option to pay for jab, experts argue, amid new wave concerns

WEKU

Coronavirus FAQ: Is it wiser to get a booster now or wait for the new fall booster?

Maybe it's not a full-blown summer surge but COVID numbers are ticking up. For those with concerns due to personal risk factors or the start of the school year, the booster question is top of mind.

Fortune

For Flagship, Moderna’s COVID-19 vaccine is a tough act to follow

Unorthodox, brash, and sometimes controversial, Flagship Pioneering is looking for its next blockbuster.

Investors Business Daily

Moderna's Game Over? Not Quite, As Company Boosts Its 2023 Outlook

Moderna raised its outlook for the year on Thursday, predicting $6 billion to $8 billion in Covid vaccine sales. MRNA stock edged down.

Investors Business Daily

Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work.

The biggest names in Covid are updating their vaccines for a fall campaign, but that might not bolster Pfizer stock and Moderna stock.

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.